vs
MUELLER INDUSTRIES INC（MLI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
MUELLER INDUSTRIES INC的季度营收约是Royalty Pharma plc的1.5倍（$962.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 16.0%，领先18.5%），Royalty Pharma plc同比增速更快（4.8% vs 4.2%），过去两年MUELLER INDUSTRIES INC的营收复合增速更高（6.4% vs 4.6%）
Mueller Industries是美国知名工业制造企业，1917年正式成立，总部坐落于美国田纳西州孟菲斯市，主营管道产品、工业金属及暖通制冷设备，2022年入选《财富》1000强榜单，是年营收达数十亿美元的公开上市企业。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MLI vs RPRX — 直观对比
营收规模更大
MLI
是对方的1.5倍
$622.0M
营收增速更快
RPRX
高出0.6%
4.2%
净利率更高
RPRX
高出18.5%
16.0%
两年增速更快
MLI
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.4M | $622.0M |
| 净利润 | $153.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 17.9% | 62.4% |
| 净利率 | 16.0% | 34.4% |
| 营收同比 | 4.2% | 4.8% |
| 净利润同比 | 11.7% | 2.9% |
| 每股收益（稀释后） | $1.37 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLIRPRX
| Q4 25 | $962.4M | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $1.0B | $568.2M | ||
| Q4 24 | $923.5M | $593.6M | ||
| Q3 24 | $997.8M | $564.7M | ||
| Q2 24 | $997.7M | $537.3M | ||
| Q1 24 | $849.7M | $568.0M |
净利润MLIRPRX
| Q4 25 | $153.7M | $214.2M | ||
| Q3 25 | $208.1M | $288.2M | ||
| Q2 25 | $245.9M | $30.2M | ||
| Q1 25 | $157.4M | $238.3M | ||
| Q4 24 | $137.7M | $208.2M | ||
| Q3 24 | $168.7M | $544.0M | ||
| Q2 24 | $160.2M | $102.0M | ||
| Q1 24 | $138.4M | $4.8M |
毛利率MLIRPRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 27.6% | — | ||
| Q2 24 | 27.3% | — | ||
| Q1 24 | 28.4% | — |
营业利润率MLIRPRX
| Q4 25 | 17.9% | 62.4% | ||
| Q3 25 | 25.6% | 70.1% | ||
| Q2 25 | 26.7% | 36.3% | ||
| Q1 25 | 20.6% | 94.0% | ||
| Q4 24 | 18.4% | 60.9% | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 21.0% | 50.2% | ||
| Q1 24 | 21.6% | -13.0% |
净利率MLIRPRX
| Q4 25 | 16.0% | 34.4% | ||
| Q3 25 | 19.3% | 47.3% | ||
| Q2 25 | 21.6% | 5.2% | ||
| Q1 25 | 15.7% | 41.9% | ||
| Q4 24 | 14.9% | 35.1% | ||
| Q3 24 | 16.9% | 96.3% | ||
| Q2 24 | 16.1% | 19.0% | ||
| Q1 24 | 16.3% | 0.8% |
每股收益（稀释后）MLIRPRX
| Q4 25 | $1.37 | $0.49 | ||
| Q3 25 | $1.88 | $0.67 | ||
| Q2 25 | $2.22 | $0.07 | ||
| Q1 25 | $1.39 | $0.55 | ||
| Q4 24 | $1.21 | $0.46 | ||
| Q3 24 | $1.48 | $1.21 | ||
| Q2 24 | $1.41 | $0.23 | ||
| Q1 24 | $1.21 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $3.2B | $9.7B |
| 总资产 | $3.7B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MLIRPRX
| Q4 25 | $1.4B | $618.7M | ||
| Q3 25 | $1.3B | $938.9M | ||
| Q2 25 | $1.1B | $631.9M | ||
| Q1 25 | $873.6M | $1.1B | ||
| Q4 24 | $1.1B | $929.0M | ||
| Q3 24 | $969.6M | $950.1M | ||
| Q2 24 | $825.7M | $1.8B | ||
| Q1 24 | $1.4B | $843.0M |
总债务MLIRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益MLIRPRX
| Q4 25 | $3.2B | $9.7B | ||
| Q3 25 | $3.1B | $9.6B | ||
| Q2 25 | $2.9B | $9.5B | ||
| Q1 25 | $2.7B | $9.8B | ||
| Q4 24 | $2.8B | $10.3B | ||
| Q3 24 | $2.7B | $10.3B | ||
| Q2 24 | $2.5B | $9.8B | ||
| Q1 24 | $2.4B | $9.9B |
总资产MLIRPRX
| Q4 25 | $3.7B | $19.6B | ||
| Q3 25 | $3.7B | $19.3B | ||
| Q2 25 | $3.5B | $18.3B | ||
| Q1 25 | $3.2B | $17.6B | ||
| Q4 24 | $3.3B | $18.2B | ||
| Q3 24 | $3.2B | $18.0B | ||
| Q2 24 | $3.1B | $17.7B | ||
| Q1 24 | $2.9B | $16.1B |
负债/权益比MLIRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $121.4M | — |
| 自由现金流率自由现金流/营收 | 12.6% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | 0.92× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $686.6M | — |
8季度趋势，按日历期对齐
经营现金流MLIRPRX
| Q4 25 | $141.2M | $827.1M | ||
| Q3 25 | $310.1M | $702.6M | ||
| Q2 25 | $190.6M | $364.0M | ||
| Q1 25 | $113.6M | $596.1M | ||
| Q4 24 | $140.1M | $742.5M | ||
| Q3 24 | $231.4M | $703.6M | ||
| Q2 24 | $100.8M | $658.2M | ||
| Q1 24 | $173.6M | $664.6M |
自由现金流MLIRPRX
| Q4 25 | $121.4M | — | ||
| Q3 25 | $291.8M | — | ||
| Q2 25 | $176.5M | — | ||
| Q1 25 | $97.0M | — | ||
| Q4 24 | $111.2M | — | ||
| Q3 24 | $205.7M | — | ||
| Q2 24 | $91.6M | — | ||
| Q1 24 | $157.2M | — |
自由现金流率MLIRPRX
| Q4 25 | 12.6% | — | ||
| Q3 25 | 27.1% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 9.7% | — | ||
| Q4 24 | 12.0% | — | ||
| Q3 24 | 20.6% | — | ||
| Q2 24 | 9.2% | — | ||
| Q1 24 | 18.5% | — |
资本支出强度MLIRPRX
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 1.9% | — |
现金转化率MLIRPRX
| Q4 25 | 0.92× | 3.86× | ||
| Q3 25 | 1.49× | 2.44× | ||
| Q2 25 | 0.78× | 12.06× | ||
| Q1 25 | 0.72× | 2.50× | ||
| Q4 24 | 1.02× | 3.57× | ||
| Q3 24 | 1.37× | 1.29× | ||
| Q2 24 | 0.63× | 6.45× | ||
| Q1 24 | 1.25× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MLI
| Tube And Fittings | $484.6M | 50% |
| Industrial Metals | $252.2M | 26% |
| Valves And Plumbing Specialties | $122.5M | 13% |
| Flex Duct And Other HVAC Components | $80.8M | 8% |
| Other Products | $14.9M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
